Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 6 |
NetGPI | no | yes: 0, no: 6 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005787 | signal peptidase complex | 3 | 7 |
GO:0016020 | membrane | 2 | 7 |
GO:0032991 | protein-containing complex | 1 | 7 |
GO:0098796 | membrane protein complex | 2 | 7 |
GO:0110165 | cellular anatomical entity | 1 | 7 |
GO:0140534 | endoplasmic reticulum protein-containing complex | 2 | 7 |
GO:1902494 | catalytic complex | 2 | 7 |
GO:1905368 | peptidase complex | 3 | 7 |
Related structures:
AlphaFold database: Q4QFC7
Term | Name | Level | Count |
---|---|---|---|
GO:0006465 | signal peptide processing | 5 | 7 |
GO:0006508 | proteolysis | 4 | 7 |
GO:0006518 | peptide metabolic process | 4 | 7 |
GO:0006605 | protein targeting | 5 | 2 |
GO:0006807 | nitrogen compound metabolic process | 2 | 7 |
GO:0006810 | transport | 3 | 2 |
GO:0006886 | intracellular protein transport | 4 | 2 |
GO:0008104 | protein localization | 4 | 2 |
GO:0008152 | metabolic process | 1 | 7 |
GO:0009987 | cellular process | 1 | 2 |
GO:0015031 | protein transport | 4 | 2 |
GO:0016485 | protein processing | 5 | 7 |
GO:0019538 | protein metabolic process | 3 | 7 |
GO:0033036 | macromolecule localization | 2 | 2 |
GO:0033365 | protein localization to organelle | 5 | 2 |
GO:0043170 | macromolecule metabolic process | 3 | 7 |
GO:0043603 | amide metabolic process | 3 | 7 |
GO:0044238 | primary metabolic process | 2 | 7 |
GO:0045047 | protein targeting to ER | 6 | 2 |
GO:0045184 | establishment of protein localization | 3 | 2 |
GO:0046907 | intracellular transport | 3 | 2 |
GO:0051179 | localization | 1 | 2 |
GO:0051234 | establishment of localization | 2 | 2 |
GO:0051604 | protein maturation | 4 | 7 |
GO:0051641 | cellular localization | 2 | 2 |
GO:0051649 | establishment of localization in cell | 3 | 2 |
GO:0070727 | cellular macromolecule localization | 3 | 2 |
GO:0070972 | protein localization to endoplasmic reticulum | 6 | 2 |
GO:0071702 | organic substance transport | 4 | 2 |
GO:0071704 | organic substance metabolic process | 2 | 7 |
GO:0071705 | nitrogen compound transport | 4 | 2 |
GO:0072594 | establishment of protein localization to organelle | 4 | 2 |
GO:0072599 | establishment of protein localization to endoplasmic reticulum | 5 | 2 |
GO:1901564 | organonitrogen compound metabolic process | 3 | 7 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 66 | 70 | PF00656 | 0.481 |
CLV_C14_Caspase3-7 | 78 | 82 | PF00656 | 0.426 |
CLV_NRD_NRD_1 | 111 | 113 | PF00675 | 0.594 |
CLV_NRD_NRD_1 | 196 | 198 | PF00675 | 0.575 |
CLV_NRD_NRD_1 | 200 | 202 | PF00675 | 0.583 |
CLV_PCSK_KEX2_1 | 196 | 198 | PF00082 | 0.572 |
CLV_PCSK_KEX2_1 | 200 | 202 | PF00082 | 0.599 |
CLV_PCSK_KEX2_1 | 257 | 259 | PF00082 | 0.565 |
CLV_PCSK_PC1ET2_1 | 257 | 259 | PF00082 | 0.565 |
CLV_PCSK_PC7_1 | 196 | 202 | PF00082 | 0.587 |
CLV_PCSK_SKI1_1 | 133 | 137 | PF00082 | 0.475 |
CLV_PCSK_SKI1_1 | 191 | 195 | PF00082 | 0.656 |
CLV_PCSK_SKI1_1 | 201 | 205 | PF00082 | 0.631 |
CLV_PCSK_SKI1_1 | 258 | 262 | PF00082 | 0.522 |
DOC_MAPK_gen_1 | 119 | 128 | PF00069 | 0.469 |
DOC_MAPK_HePTP_8 | 126 | 138 | PF00069 | 0.329 |
DOC_MAPK_MEF2A_6 | 129 | 138 | PF00069 | 0.275 |
DOC_USP7_MATH_1 | 103 | 107 | PF00917 | 0.443 |
DOC_USP7_MATH_1 | 164 | 168 | PF00917 | 0.344 |
DOC_USP7_MATH_1 | 41 | 45 | PF00917 | 0.416 |
DOC_WW_Pin1_4 | 142 | 147 | PF00397 | 0.329 |
DOC_WW_Pin1_4 | 216 | 221 | PF00397 | 0.522 |
DOC_WW_Pin1_4 | 56 | 61 | PF00397 | 0.350 |
LIG_14-3-3_CanoR_1 | 181 | 186 | PF00244 | 0.428 |
LIG_14-3-3_CanoR_1 | 47 | 52 | PF00244 | 0.343 |
LIG_14-3-3_CanoR_1 | 5 | 12 | PF00244 | 0.590 |
LIG_AP2alpha_1 | 268 | 272 | PF02296 | 0.349 |
LIG_BRCT_BRCA1_1 | 140 | 144 | PF00533 | 0.329 |
LIG_DLG_GKlike_1 | 47 | 54 | PF00625 | 0.281 |
LIG_FHA_1 | 150 | 156 | PF00498 | 0.275 |
LIG_FHA_1 | 20 | 26 | PF00498 | 0.371 |
LIG_FHA_1 | 279 | 285 | PF00498 | 0.386 |
LIG_FHA_2 | 76 | 82 | PF00498 | 0.470 |
LIG_LIR_Gen_1 | 49 | 57 | PF02991 | 0.276 |
LIG_LIR_Nem_3 | 264 | 268 | PF02991 | 0.372 |
LIG_LIR_Nem_3 | 294 | 299 | PF02991 | 0.362 |
LIG_LIR_Nem_3 | 49 | 54 | PF02991 | 0.350 |
LIG_Pex14_2 | 144 | 148 | PF04695 | 0.275 |
LIG_Pex14_2 | 159 | 163 | PF04695 | 0.275 |
LIG_Pex14_2 | 268 | 272 | PF04695 | 0.349 |
LIG_PTB_Apo_2 | 259 | 266 | PF02174 | 0.319 |
LIG_SH2_SRC | 251 | 254 | PF00017 | 0.348 |
LIG_SH2_STAT5 | 137 | 140 | PF00017 | 0.303 |
LIG_SH2_STAT5 | 156 | 159 | PF00017 | 0.303 |
LIG_SH2_STAT5 | 251 | 254 | PF00017 | 0.361 |
LIG_SH2_STAT5 | 267 | 270 | PF00017 | 0.347 |
LIG_SH3_3 | 176 | 182 | PF00018 | 0.285 |
LIG_SH3_3 | 307 | 313 | PF00018 | 0.389 |
LIG_SH3_3 | 33 | 39 | PF00018 | 0.421 |
LIG_SH3_3 | 54 | 60 | PF00018 | 0.382 |
LIG_SH3_3 | 62 | 68 | PF00018 | 0.503 |
LIG_SH3_3 | 97 | 103 | PF00018 | 0.462 |
LIG_SUMO_SIM_anti_2 | 172 | 177 | PF11976 | 0.329 |
LIG_SUMO_SIM_anti_2 | 281 | 286 | PF11976 | 0.371 |
LIG_SUMO_SIM_anti_2 | 92 | 99 | PF11976 | 0.361 |
LIG_SUMO_SIM_par_1 | 172 | 177 | PF11976 | 0.329 |
LIG_TRAF2_1 | 226 | 229 | PF00917 | 0.422 |
LIG_WRC_WIRS_1 | 156 | 161 | PF05994 | 0.275 |
LIG_WRC_WIRS_1 | 48 | 53 | PF05994 | 0.352 |
MOD_CK1_1 | 14 | 20 | PF00069 | 0.312 |
MOD_CK1_1 | 49 | 55 | PF00069 | 0.332 |
MOD_CK1_1 | 77 | 83 | PF00069 | 0.449 |
MOD_CK2_1 | 204 | 210 | PF00069 | 0.504 |
MOD_CK2_1 | 89 | 95 | PF00069 | 0.355 |
MOD_GlcNHglycan | 138 | 141 | PF01048 | 0.475 |
MOD_GlcNHglycan | 16 | 19 | PF01048 | 0.388 |
MOD_GlcNHglycan | 166 | 169 | PF01048 | 0.495 |
MOD_GlcNHglycan | 293 | 296 | PF01048 | 0.570 |
MOD_GlcNHglycan | 43 | 46 | PF01048 | 0.493 |
MOD_GlcNHglycan | 51 | 54 | PF01048 | 0.486 |
MOD_GSK3_1 | 138 | 145 | PF00069 | 0.329 |
MOD_GSK3_1 | 19 | 26 | PF00069 | 0.371 |
MOD_GSK3_1 | 216 | 223 | PF00069 | 0.494 |
MOD_LATS_1 | 56 | 62 | PF00433 | 0.400 |
MOD_N-GLC_1 | 261 | 266 | PF02516 | 0.521 |
MOD_NEK2_1 | 12 | 17 | PF00069 | 0.380 |
MOD_NEK2_1 | 136 | 141 | PF00069 | 0.283 |
MOD_NEK2_1 | 19 | 24 | PF00069 | 0.325 |
MOD_NEK2_1 | 236 | 241 | PF00069 | 0.392 |
MOD_NEK2_1 | 25 | 30 | PF00069 | 0.263 |
MOD_NEK2_1 | 261 | 266 | PF00069 | 0.321 |
MOD_NEK2_1 | 272 | 277 | PF00069 | 0.357 |
MOD_NEK2_1 | 291 | 296 | PF00069 | 0.294 |
MOD_PKA_2 | 210 | 216 | PF00069 | 0.533 |
MOD_PKA_2 | 46 | 52 | PF00069 | 0.346 |
MOD_PKA_2 | 74 | 80 | PF00069 | 0.403 |
MOD_Plk_1 | 236 | 242 | PF00069 | 0.363 |
MOD_Plk_1 | 261 | 267 | PF00069 | 0.324 |
MOD_Plk_1 | 272 | 278 | PF00069 | 0.354 |
MOD_Plk_4 | 155 | 161 | PF00069 | 0.416 |
MOD_Plk_4 | 220 | 226 | PF00069 | 0.397 |
MOD_Plk_4 | 246 | 252 | PF00069 | 0.384 |
MOD_Plk_4 | 27 | 33 | PF00069 | 0.402 |
MOD_Plk_4 | 58 | 64 | PF00069 | 0.399 |
MOD_ProDKin_1 | 142 | 148 | PF00069 | 0.329 |
MOD_ProDKin_1 | 216 | 222 | PF00069 | 0.518 |
MOD_ProDKin_1 | 56 | 62 | PF00069 | 0.351 |
TRG_DiLeu_BaEn_4 | 228 | 234 | PF01217 | 0.394 |
TRG_ENDOCYTIC_2 | 156 | 159 | PF00928 | 0.374 |
TRG_ENDOCYTIC_2 | 288 | 291 | PF00928 | 0.310 |
TRG_ER_diArg_1 | 117 | 120 | PF00400 | 0.355 |
TRG_ER_diArg_1 | 195 | 197 | PF00400 | 0.365 |
TRG_ER_diArg_1 | 37 | 40 | PF00400 | 0.385 |
TRG_ER_diArg_1 | 4 | 7 | PF00400 | 0.586 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P7I7 | Leptomonas seymouri | 57% | 100% |
A0A3S5H6U6 | Leishmania donovani | 95% | 100% |
A4H830 | Leishmania braziliensis | 77% | 99% |
A4HWF6 | Leishmania infantum | 95% | 100% |
E9AQ55 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 90% | 100% |